Literature DB >> 645583

Single and multiple dose pharmacokinetics of oral quinidine sulfate and gluconate.

H R Ochs, D J Greenblatt, E Woo, K Franke, H J Pfeifer, T W Smith.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 645583     DOI: 10.1016/0002-9149(78)90830-5

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


× No keyword cloud information.
  11 in total

1.  Pharmacokinetics of quinidine in male patients. A population analysis.

Authors:  C N Verme; T M Ludden; W A Clementi; S C Harris
Journal:  Clin Pharmacokinet       Date:  1992-06       Impact factor: 6.447

2.  The pharmacokinetics and pharmacodynamics of quinidine and 3-hydroxyquinidine.

Authors:  R A Wooding-Scott; J Smalley; J Visco; R L Slaughter
Journal:  Br J Clin Pharmacol       Date:  1988-10       Impact factor: 4.335

3.  Divergence in pharmacokinetic parameters of quinidine obtained by specific and nonspecific assay methods.

Authors:  T W Guentert; R A Upton; N H Holford; S Riegelman
Journal:  J Pharmacokinet Biopharm       Date:  1979-06

Review 4.  Practical optimisation of antiarrhythmic drug therapy using pharmacokinetic principles.

Authors:  J L Bauman; M D Schoen; T J Hoon
Journal:  Clin Pharmacokinet       Date:  1991-02       Impact factor: 6.447

5.  Comparative bioavailability study of three sustained release quinidine formulations.

Authors:  W A Mahon; J S Leeder; M M Brill-Edwards; J Correia; S M MacLeod
Journal:  Clin Pharmacokinet       Date:  1987-08       Impact factor: 6.447

Review 6.  Clinical pharmacokinetics of quinidine.

Authors:  H R Ochs; D J Greenblatt; E Woo
Journal:  Clin Pharmacokinet       Date:  1980 Mar-Apr       Impact factor: 6.447

Review 7.  First-pass elimination. Basic concepts and clinical consequences.

Authors:  S M Pond; T N Tozer
Journal:  Clin Pharmacokinet       Date:  1984 Jan-Feb       Impact factor: 6.447

8.  Gastrointestinal absorption of quinidine from some solutions and commercial tablets.

Authors:  T W Guentert; R A Upton; N H Holford; A Bostrom; S Riegelman
Journal:  J Pharmacokinet Biopharm       Date:  1980-06

Review 9.  Individual variation in first-pass metabolism.

Authors:  Y K Tam
Journal:  Clin Pharmacokinet       Date:  1993-10       Impact factor: 6.447

Review 10.  Carboxylic Acid Counterions in FDA-Approved Pharmaceutical Salts.

Authors:  Sonali S Bharate
Journal:  Pharm Res       Date:  2021-07-23       Impact factor: 4.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.